• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oxygen Biotherapeutics Inc

+ Add to Watchlist

OXBT:US

3.9699 USD 0.0299 0.76%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Oxygen Biotherapeutics Inc (OXBT)

Open: 3.9100 Day's Range: 3.8200 - 3.9800 Volume: 163,860
Previous Close: 3.9400 52wk Range: 1.1900 - 11.4000 1-Yr Rtn: +164.66%

Stock Chart for OXBT

No chart data available.
  • OXBT:US 3.9600
  • 1D
  • 1M
  • 1Y
3.9400
Interactive OXBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OXBT

Current P/E Ratio (ttm) -
Estimated P/E(04/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -6.3300
Est. EPS (USD) (04/2014) -1.4300
Est. PEG Ratio -
Market Cap (M USD) 110.59
Shares Outstanding (M) 27.86
30 Day Average Volume 238,674
Price/Book (mrq) 1.7911
Price/Sale (ttm) 10.7553
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OXBT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OXBT

Oxygen Biotherapeutics Inc. is a biomedical product development company. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, liquid ventilation and implanted glucose sensing.

John P KelleyChief Executive OfficerMichael B JebsenPresident/CFO
Nancy J HecoxSecretary
More Company Profile & Key Executives for OXBT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil